Mazanti-Andersen advised Hemab on the deal.The Denmark and US-based biotech company Hemab raised USD 135 million in oversubscribed series B financing. Access Biotechnology led the round with…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now